ITRM stock

Iterum Therapeutics Plc (ITRM) receives a Hold rating from Gabelli & Co
Samantha Gray
Iterum Therapeutics Plc’s recent filing unveils that its Director Dunne Michael W. acquired Company’s shares for reported $10854.0 on Aug ...

Iterum Therapeutics Plc’s recent filing unveils that its Director Dunne Michael W. acquired Company’s shares for reported $10854.0 on Aug ...